The value of the recently granted 12-lead ECG patch patent is in addressing the market need for multi-week, continuous monitoring while the AIMIGo solution is always with the patient, providing a ...

The value of the recently granted 12-lead ECG patch patent is in addressing the market need for multi-week, continuous monitoring, while the AIMIGo solution is always with the patient, long term ...

Patented Technology Provides Protection for HeartBeam AIMIGo Credit Card-sized Device in European Market HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first ...

HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere, announced today that its ...

HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere, announced today that its patent ...

HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere, announced today that its ...